TechnologyResearchers assess diagnostic criteria for canine glioma

Researchers assess diagnostic criteria for canine glioma


- Advertisment -spot_imgspot_imgspot_imgspot_img
Researchers assess diagnostic criteria for canine glioma
Credit: Josef Reckziegel on Unsplash

A multi-institutional team led by North Carolina State University researchers has found that using recently released criteria for the diagnosis of canine glioma resulted in strong diagnostic consensus among pathologists. The findings not only pave the way for more standardized diagnostic criteria for dogs with brain tumors, but also create a useful baseline to support larger inter-institutional studies that could aid dogs and humans with glioma.

Gliomas are a family of tumors that occur in the brain and spinal cord and comprise 30-40% of intracranial tumors in dogs. Humans can suffer from these same tumors; however, in human medicine, physicians have a diagnostic algorithm based on molecular and microscopic features that help them identify and agree on the subtype and grade (or severity) of glioma.

Dogs did not have a similar set of until 2018, when the Comparative Brain Tumor Consortium (CBTC) created a set of aimed at helping veterinary pathologists achieve diagnostic consensus.

“The CBTC system of diagnostic criteria could be very useful not only in the clinical diagnosis of canine patients, but also in enabling inter-institutional research collaboration, since it has everyone speaking the same language, diagnostically speaking,” says Gregory Krane, co-lead author of the paper, a veterinary pathologist currently working at Moderna and former Ph.D. student at NC State. “To that end, we wanted to conduct a real-world assessment of the system.”

Krane obtained 85 glioma samples taken from dogs examined at NC State between 2006 and 2018. Five pathologists—one M.D. neuropathologist, two veterinary neuropathologists, and two veterinary pathologists without subspecialty training in neuropathology—separately examined the samples using the CBTC guidelines.

There are three types of canine glioma: oligodendroglioma, astrocytoma and undefined glioma. Each of these subtypes can be further classified as low- or high-grade based on certain microscopic features. The pathologists utilized both microscopy and immunohistochemistry to analyze the samples.

Consensus was defined as three or more of the five pathologists agreeing on the subtype and grade of the tumor. A consensus diagnosis was achieved for 71 out of 85 (84%) cases.

Keith Shockley, co-first author of the study and a biostatistician at the National Institute of Environmental Health Sciences (NIEHS), helped perform an advanced statistical analysis on the diagnoses to obtain a kappa statistic, which estimates the degree to which different raters agree beyond what would be predicted by chance alone.

The kappa statistic is regularly used in human studies to quantify diagnostic consensus, predominantly in the fields of pathology and radiology. Agreement levels for the kappa statistic are defined as poor, slight, fair, moderate, substantial, almost perfect, and perfect. The kappa statistic for the CBTC criteria was moderate, which was similar to that for most human glioma studies.

“These results show that the CBTC system is similarly reliable to those used in human studies,” Krane says. “Hopefully this will support multi-institutional studies with large case numbers, so that we can start leveraging our data to help advance diagnostic and treatment options for both canine and human glioma patients.

“The study also shows that even with detailed diagnostic criteria, pathologist consensus is often not 100%. For a clinical setting, practitioners should be comfortable talking with their pathologist if the diagnosis is not compatible with the rest of the clinical picture, and in the research setting, investigators can strengthen their studies by incorporating groups of pathologists into the diagnostic review.”

The study appears in Veterinary and Comparative Oncology.

More information:
Gregory A. Krane et al, Inter‐pathologist agreement on diagnosis, classification and grading of canine glioma, Veterinary and Comparative Oncology (2022). DOI: 10.1111/vco.12853

Researchers assess diagnostic criteria for canine glioma (2022, August 15)
retrieved 15 August 2022

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Read More

Latest news

RACO Investment founder Randall Castillo Ortega explains what it takes to be an effective leader

Financial and business process expert Randall Castillo Ortega of RACO Investment provides an in-depth look at what it...

Angelo Babb explains the different type of digital currencies available to consumers

Cryptocurrency expert Angelo Babb offers insight into the difference between digital currencies and cryptocurrencies, and the roles they...

Allen Woo offers actions and strategies for retaining human talent in a company

There is no doubt that talent retention in companies is a difficult task to achieve, but Allen Woo’s...

Kimberly Rosales explains why cryptocurrencies are important for foreign trade

Foreign trade has always depended on many factors, cryptocurrencies being one of the most recent, and that is...
- Advertisement -spot_imgspot_imgspot_imgspot_img
- Advertisement -spot_imgspot_imgspot_imgspot_img

Ann Marie Puig discusses the challenges businesses still face after the COVID-19 pandemic

Global business consultant Ann Marie Puig offers valuable insight into how industries are changing because of COVID-19 and...

See the Pogues As Castaways in Outer Banks Season 3 Teaser

The Pogues have been exiled in the first teaser for season three of Netflix's Outer Banks. Watch the trailer...

Must read

- Advertisement -spot_imgspot_imgspot_img

You might also likeRELATED
Recommended to you